The report "Dietary
Supplements Market by type (Botanicals, Vitamins, Minerals, Amino Acids,
Enzymes, Probiotics), Function (Additional Supplements, Medicinal Supplements,
Sports Nutrition), Mode of Application, Target Consumer and Region - Global
Forecast to 2027", is estimated at USD 155.2 billion in 2022; it is
projected to grow at a CAGR of 7.3% to reach USD 220.8 billion by 2027. The
ageing population in the eastern and western countries have propelled the
market growth of dietary supplements. According to the UKs Food Standard Agency
(FSA), the majority of supplement consumers, are over 55 years old. These
supplements are bought in the belief that old age can be joyful and pain-free,
with a body of research pointing to memory enhancement, joint strengthening,
and a vitality boost of glucosamine, ginkgo, and ginseng.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=973
The Botanical segment
by type is projected to achieve the Highest CAGR growth in the Dietary
Supplements market.
The demand for the botanicals ingredients included in the
dietary supplements solutions had driven because of their consumer-perceived
benefits, such as functional benefits and being "closer-to-nature,"
as well as their ability to impart pleasant flavours. Furthermore, attractive
flavours and colors produced from natural sources are a vital part in dietary
supplements solutions. Some of the advantages of botanical dietary supplements
are, Low cost compared to prescription drug, It can be obtained without a
prescription, Has the potential to be effective, despite the lack of evidence,
and Contribute to a sense of self-sufficiency
By function, the
additional supplements segment is estimated to account for the largest market
share in the Dietary Supplements market.
This category includes supplements that can be consumed
without a doctors prescription. Minerals, herbs or other botanicals, amino acids,
enzymes, and a variety of other ingredients can be found in dietary
supplements. Tablets, capsules, gummies, and powder, as well as drinks and
energy bars, are all forms of dietary supplements. According to the National
Center for Health Statistics, 57.6% of US adults aged 20 and above used a
dietary supplement, with women (63.8%) using more than men (50.8%). Dietary
supplement use increased with age in both sexes but was highest in women aged
60 and above (80.2%)
The tablet form segment
by mode of application is estimated to account for the largest market share of
the Dietary Supplements market over the forecast period.
Longevity of tablet form drives market growth. Compressed
tablets are typically meant to be swallowed without being broken, chewed, or
dissolved. This tablet type will usually only begin to break down after
reaching the stomach (or some other stretch of the gastrointestinal tract).
Compressed tablets have the advantage of being generally stable and available
in various sizes and shapes. As a result, a wide range of dietary supplements
can be easily incorporated into tablet form. For this reason, compressed
tablets are popular
Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=973
Asia Pacific is
projected to achieve the highest CAGR growth in the Dietary Supplements market.
The rising influence of westernization, the growing
millennial population, and increasing awareness are the key drivers of market
growth. According to the UN, in 2019, 60% of the 1.8 billion global population
of millennials reside in Asia. This population is active, enthusiastic about
fitness, and continuously seeking innovative products. As a result, millennials
are prominent consumers of dietary supplements in the region. Veganism has also
become popular in the region, alongside rising demand for plant-based food
products, especially in India, China, Australia, and Indonesia. This key factor
would eventually pave the way for herbal supplements to grow significantly in
value sales during the forecast period in the Asia Pacific.
The key players in this market include Amway Corp (US),
Herbalife International of America, INC. (US), ADM (US), Pfizer INC (US),
Abbott (US), Nestle (Switzerland), Otsuka Holding Co, LTD (Japan), H&H
Group (China), Arkopharma (France), Bayer AG (Germany), Glanbia Plc (Ireland),
Natures Sunshine Products Inc (US), Fancl Corporation (Japan), Danisco
(Denmark), Bionova (India), American Health (US), Pure Encapsulations LLC (US),
GlaxoSmithKline, PLC (UK). These players in this market are focusing on
increasing their presence through agreements and collaborations. These
companies have a strong presence in North America, Asia Pacific and Europe.
They also have manufacturing facilities along with strong distribution networks
across these regions.
No comments:
Post a Comment